This website contains forward-looking information. Forward-looking information is based on the current estimates, opinions and beliefs of Breathe BioMedical, as well as various assumptions and information currently available to Breathe BioMedical. Although Breathe BioMedical…
While mammography is currently the standard of care for breast cancer screening, dense breast tissue can significantly degrade results. Alternatively, infrared spectroscopy analysis of breath offers a highly sensitive method for identifying exhaled volatile…
Population-level screening programs aimed at early detection and treatment of breast cancer saves lives. Analyzing breath using infrared spectroscopy offers a highly sensitive, non-invasive, and cost-effective mechanism for identifying exhaled volatile organic chemicals, and…
Early diagnosis of lung cancer greatly improves the likelihood of survival and remission, but limitations in existing technologies like low-dose computed tomography have prevented the implementation of widespread screening programs. Breath-based solutions that seek…
Currently low-dose computed tomography is used for lung cancer (LC) screening, but is limited by radiation exposure, cost, and a high false detection rate (1,2). An accurate, accessible and affordable screening technology is needed…
Nearly 80% of lung cancer cases are discovered when the disease has already metastasized and survival rates are significantly reduced. Screening is critical to catch the disease in its early, treatable stages. In this…
